Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 9/20 | 0.59 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.59 |
| ▸ | RARB | P10826 | 1/20 | 0.59 |
| ▸ | RARG | P13631 | 1/20 | 0.59 |
| ▸ | DRD1 | P21728 | 1/20 | 0.59 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | PGR | P06401 | 2/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Limaprost SCHEMBL30532999 | 1.00 | PTGIR (0.59) | PTGIRPTGER2TSHRPTGER4HPGD | |
| Limaprost SCHEMBL20815450 | 1.00 | PTGIR (0.59) | PTGIRPTGER2TSHRPTGER4HPGD | |
| Limaprost SCHEMBL960148 | 1.00 | PTGIR (0.59) | PTGIRPTGER2TSHRPTGER4HPGD | |
| Limaprost SCHEMBL23352904 | 1.00 | PTGIR (0.59) | PTGIRPTGER2TSHRPTGER4HPGD | |
| Limaprost SCHEMBL960149 | 1.00 | PTGIR (0.59) | PTGIRPTGER2TSHRPTGER4HPGD | |
| Limaprost SCHEMBL24342042 | 1.00 | PTGIR (0.59) | PTGIRPTGER2TSHRPTGER4HPGD | |
| Limaprost SCHEMBL30533051 | 1.00 | PTGIR (0.59) | PTGIRPTGER2TSHRPTGER4HPGD | |
| SCHEMBL960063 | 0.96 | PTGIR (0.65) | PTGIRPTGER2TSHRPTGER4HPGD | |
| SCHEMBL960062 | 0.96 | PTGIR (0.65) | PTGIRPTGER2TSHRPTGER4HPGD | |
| SCHEMBL960065 | 0.96 | PTGIR (0.65) | PTGIRPTGER2TSHRPTGER4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739302-A2 | HYALURONIC ACID BASED DRUG DELIVERY SYSTEMS | Cella Therapeutics, LLC (US) | 2026-05-13 | — | — | EP | claimed |
| US-12569437-B2 | Disease-site-specific liposomal formulation | OSAKA UNIVERSITY (JP) | 2026-03-10 | — | — | US | claimed |
| CN-120076792-A | Liposome pharmaceutical composition and preparation method and application thereof | 上海济昀生物科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119947708-A | Liposome and preparation method and application thereof | 上海济昀生物科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| EP-3895686-B1 | NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS PREVENTION AND TREATMENT | FRAUNHOFER GES FORSCHUNG (DE) | 2025-04-09 | — | — | EP | claimed |
| WO-2025010288-A2 | HYALURONIC ACID BASED DRUG DELIVERY SYSTEMS | VISUS THERAPEUTICS, INC. (US) | 2025-01-09 | — | — | WO | claimed |
| CN-118894772-A | Preparation method of key intermediate of high optical purity limaprost | 常州博海威医药科技股份有限公司 | 2024-11-05 | — | — | CN | claimed |
| CN-118191145-A | Method for determining concentration of beraprost sodium in blood plasma | 丽健(广东)动物保健有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-115666532-B | Sustained release preparation containing limaprost | 研成精密化学株式会社 | 2024-06-11 | — | — | CN | claimed |
| CN-117959307-A | Medical application of limaprost | 北京泰德制药股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| WO-2000022909-A2 | SYSTEMS FOR ORAL DELIVERY | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 2000-04-27 | — | — | WO | claimed |
| EP-0989972-A1 | PROSTAGLANDIN PHARMACEUTICAL COMPOSITIONS | NICOX S.A. (FR) | 2000-04-05 | — | — | EP | claimed |
| WO-1998058910-A1 | PROSTAGLANDIN PHARMACEUTICAL COMPOSITIONS | NICOX S.A. (FR) | 1998-12-30 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |
| EP-0559911-B1 | ANTITHROMBOTIC RESIN, TUBE, FILM AND COATING | OTSUKA PHARMA CO LTD (JP) | 1997-11-26 | — | — | EP | claimed |
| WO-1995006466-A1 | TREATMENT OF ANORECTAL DISORDERS | KOREN LABORATORIES PTY. LIMITED (AU) | 1995-03-09 | — | — | WO | claimed |
| EP-0583482-A1 | REMEDY FOR WOUND OR HEMORRHOID | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1994-02-23 | — | — | EP | claimed |
| EP-0559911-A1 | ANTITHROMBOTIC RESIN, TUBE, FILM AND COATING | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 1993-09-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569437-B2 | Disease-site-specific liposomal formulation | PTGER1, PLA2R1, LPAR2 | PTGIR 17/4885PTGER2 7/4885TSHR 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.